Copper histidinate is expected to improve neurodevelopmental outcomes and survival in patients with Menkes disease, an X-linked recessive disease caused by mutations of the ATP7A copper ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback